FDA NDC Directory · JSON-LD · Markdown

IMPAVIDO

NDC 71863-135 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameMiltefosine
Labeler / ManufacturerEton Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA204684
Dosage form / routeCAPSULE · ORAL
Active ingredientsMILTEFOSINE (50 mg/1)
Marketing started20260926
Package count1

External sources

Source: openFDA. Public-domain (CC0).